Diagnostic accuracy of 11C-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma

[1]  Young Youn Cho,et al.  Does 18F-FDG Positron Emission Tomography-Computed Tomography Have a Role in Initial Staging of Hepatocellular Carcinoma? , 2014, PloS one.

[2]  U. Beuers,et al.  Diagnostic accuracy of 18F‐methylcholine positron emission tomography/computed tomography for intra‐ and extrahepatic hepatocellular carcinoma , 2014, Hepatology.

[3]  F. Montravers,et al.  Diagnostic accuracy of [18F]DOPA PET and PET/CT in patients with neuroendocrine tumors: a meta-analysis , 2013, Clinical and Translational Imaging.

[4]  V. Goh,et al.  Functional imaging techniques in hepatocellular carcinoma , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  Quanshi Wang,et al.  F-18 FDG in Conjunction With 11C-Choline PET/CT in the Diagnosis of Hepatocellular Carcinoma , 2011, Clinical nuclear medicine.

[6]  J. Kolthammer,et al.  Imaging Lipid Synthesis in Hepatocellular Carcinoma with [Methyl-11C]Choline: Correlation with In Vivo Metabolic Studies , 2011, The Journal of Nuclear Medicine.

[7]  Virginie Huchet,et al.  Detection of Hepatocellular Carcinoma with PET/CT: A Prospective Comparison of 18F-Fluorocholine and 18F-FDG in Patients with Cirrhosis or Chronic Liver Disease , 2010, The Journal of Nuclear Medicine.

[8]  G. MacLennan,et al.  PET imaging of hepatocellular carcinoma with 2-deoxy-2[18F]fluoro-D-glucose, 6-deoxy-6[18F] fluoro-D-glucose, [1-11C]-acetate and [N-methyl-11C]-choline. , 2009, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[9]  Chang-Min Kim,et al.  A Prospective Evaluation of 18F-FDG and 11C-Acetate PET/CT for Detection of Primary and Metastatic Hepatocellular Carcinoma , 2008, Journal of Nuclear Medicine.

[10]  G. Torzilli,et al.  Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis. , 2008, Archives of surgery.

[11]  J. Strain,et al.  Best cases from the AFIP: fibrolamellar hepatocellular carcinoma. , 2008, Radiographics : a review publication of the Radiological Society of North America, Inc.

[12]  G. Klintmalm,et al.  Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis , 2007, Alimentary pharmacology & therapeutics.

[13]  Khaldoun Kerrou,et al.  PET/CT in patients with hepatocellular carcinoma using [18F]fluorocholine: preliminary comparison with [18F]FDG PET/CT , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[15]  A. Burroughs,et al.  Hepatocellular carcinoma , 2003, The Lancet.

[16]  Chi-Lai Ho,et al.  11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  R. Valkema,et al.  Fluorine-18 FDG imaging in hepatocellular carcinoma using positron coincidence detection and single photon emission computed tomography. , 2002, Liver.

[18]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[19]  M. Laeeq Khan,et al.  Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. , 2000, Journal of hepatology.

[20]  S. Zeuzem,et al.  Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma , 1999, American Journal of Gastroenterology.

[21]  M P Sandler,et al.  Evaluation of benign vs malignant hepatic lesions with positron emission tomography. , 1998, Archives of surgery.

[22]  V. Mazzaferro,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[23]  H. Edmondson,et al.  Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies , 1954, Cancer.

[24]  J. Bruix,et al.  A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations? An Observational Study of the HCC East-West Study Group. , 2015, Annals of surgery.

[25]  V. Mazzaferro,et al.  EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer , 2012 .

[26]  Riccardo Lencioni,et al.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. , 2012, Journal of hepatology.

[27]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[28]  V. Mazzaferro,et al.  Resection and Liver Transplantation for Hepatocellular Carcinoma , 2005, Seminars in liver disease.